bf/NYSE:AMRX_icon.png

COM:AMNEAL

Amneal Pharmaceuticals

  • Stock

Last Close

8.41

21/11 21:00

Market Cap

2.19B

Beta: -

Volume Today

761.48K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
370.63M
-
419.14M
13.09%
435.86M
3.99%
490.02M
12.43%
510.06M
4.09%
average payables
292.23M
-
510.96M
74.85%
560.57M
9.71%
598.50M
6.77%
560.77M
6.30%
average receivables
432.53M
-
544.24M
25.83%
623.23M
14.51%
652.03M
4.62%
703.03M
7.82%
book value per share
-3.36
-
7.04
309.74%
2.63
62.73%
2.34
10.88%
2.46
5.33%
1.22
50.54%
capex per share
-1.08
-
-0.99
8.29%
-0.76
23.31%
-0.74
3.33%
-0.45
39.14%
-0.35
21.26%
-0.60
69.80%
-0.25
59.12%
capex to depreciation
-3.77
-
-2.49
34.09%
-0.71
71.60%
-0.47
33.46%
-0.28
40.19%
-0.23
19.79%
-0.38
67.26%
-0.19
50.06%
capex to operating cash flow
-1.08
-
-0.49
54.94%
-0.39
20.48%
-57.14
14,628.10%
-0.17
99.69%
-0.22
24.65%
-1.39
539.30%
-0.13
91.01%
capex to revenue
-0.12
-
-0.11
9.66%
-0.06
47.19%
-0.06
2.61%
-0.03
44.55%
-0.03
24.31%
-0.04
62.88%
-0.02
55.91%
cash per share
0.65
-
1.68
159.70%
1.14
31.75%
2.32
102.30%
1.66
28.14%
0.17
89.66%
days of inventory on hand
204.29
-
176.30
13.70%
109.23
38.04%
131.28
20.19%
134.84
2.71%
135.70
0.63%
days payables outstanding
50.36
-
198.37
293.92%
145.46
26.67%
164.20
12.88%
160.73
2.11%
137.60
14.39%
days sales outstanding
135.15
-
105.86
21.67%
136.04
28.50%
117.29
13.78%
115.72
1.34%
122.47
5.83%
debt to assets
1.11
-
0.62
44.12%
0.75
22.03%
0.73
2.71%
0.73
0.55%
0.75
2.58%
debt to equity
-3.85
-
3.00
178.01%
7.98
165.65%
8.53
6.89%
7.84
8.08%
15.46
97.32%
dividend yield
0.13
-
0.20
48.86%
0.11
45.83%
earnings yield
0.14
-
0.09
35.67%
-0.10
212.45%
-0.95
861.56%
0.10
110.74%
0.03
72.22%
-0.85
3,099.85%
-0.08
90.74%
enterprise value
3.32B
-
4.20B
26.38%
3.25B
22.58%
3.27B
0.67%
3.34B
2.09%
3.12B
6.65%
enterprise value over ebitda
12.26
-
10.10
17.60%
46.58
361.11%
9.38
79.87%
7.55
19.50%
6.98
7.48%
ev to operating cash flow
14.19
-
16.78
18.28%
1.91K
11,263.04%
8.64
99.55%
13.82
60.00%
47.92
246.77%
ev to sales
3.21
-
2.53
21.44%
2.00
20.83%
1.64
17.83%
1.60
2.84%
1.41
11.65%
free cash flow per share
-0.08
-
1.04
1,356.19%
1.20
15.27%
-0.72
160.21%
2.12
392.79%
1.27
40.12%
-0.17
113.30%
1.72
1,116.34%
free cash flow yield
-0.01
-
0.06
1,099.67%
0.09
41.85%
-0.15
269.02%
0.46
408.81%
0.27
42.87%
-0.08
132.00%
0.28
433.20%
graham net net
-10.57
-
-20.85
97.18%
-19.10
8.39%
-17.59
7.87%
-17.34
1.44%
-18.17
4.77%
graham number
10.50
-
14.54
38.44%
16.43
12.99%
4.95
69.88%
2.74
44.62%
6.80
148.28%
income quality
0.55
-
1.38
151.74%
-1.24
189.88%
-0.00
99.77%
5.53
195,741.49%
11.99
116.94%
-0.26
102.13%
-7.09
2,676.00%
intangibles to total assets
0
-
0.05
Infinity%
0.48
803.12%
0.49
2.82%
0.46
7.21%
0.45
2.07%
0.45
0.14%
0
100%
interest coverage
5.15
-
3.45
33.07%
-0.14
103.97%
-0.82
496.23%
0.62
176.42%
1.53
145.83%
1.30
15.06%
0.01
99.59%
interest debt per share
13.55
-
22.28
64.47%
22.21
0.30%
20.94
5.74%
20.23
3.38%
19.90
1.63%
inventory turnover
1.79
-
2.07
15.88%
3.34
61.41%
2.78
16.80%
2.71
2.64%
2.69
0.63%
invested capital
-3.85
-
3.00
178.01%
7.98
165.65%
8.53
6.89%
7.84
8.08%
15.46
97.32%
market cap
1.52B
-
1.91B
25.66%
1.72B
9.97%
636.75M
63.02%
673.81M
5.82%
713.34M
5.87%
300.38M
57.89%
1.07B
255.93%
net current asset value
-945.54M
-
-2.17B
129.47%
-2.11B
2.80%
-2.11B
0.03%
-2.05B
2.70%
-2.18B
6.14%
net debt to ebitda
5.20
-
5.96
14.54%
37.46
528.45%
7.45
80.12%
5.94
20.27%
6.31
6.30%
net income per share
1.81
-
1.46
19.16%
-1.33
191.38%
-4.57
242.55%
0.47
110.18%
0.14
70.88%
-1.69
1,346.29%
-0.48
71.75%
operating cash flow per share
1.00
-
2.04
103.53%
1.97
3.56%
0.01
99.34%
2.57
19,816.56%
1.62
36.83%
0.43
73.44%
1.96
354.92%
payables turnover
7.25
-
1.84
74.61%
2.51
36.37%
2.22
11.41%
2.27
2.16%
2.65
16.81%
receivables turnover
2.70
-
3.45
27.66%
2.68
22.18%
3.11
15.98%
3.15
1.36%
2.98
5.51%
research and ddevelopement to revenue
0.20
-
0.19
7.66%
0.13
31.85%
0.12
1.72%
0.10
23.10%
0.10
4.65%
0.09
9.66%
0.07
24.25%
return on tangible assets
0.13
-
-0.07
156.64%
-0.32
333.45%
0.03
109.72%
0.01
70.60%
-0.12
1,408.43%
revenue per share
8.86
-
9.00
1.52%
13.07
45.22%
12.31
5.80%
13.51
9.77%
14.06
4.03%
14.66
4.25%
13.59
7.28%
roe
-0.43
-
-0.19
56.43%
-1.74
819.18%
0.20
111.42%
0.05
72.35%
-1.38
2,619.65%
roic
0.21
-
-0.01
102.53%
-0.12
2,052.59%
-0.05
55.80%
0.04
177.91%
0.07
68.45%
sales general and administrative to revenue
0.12
-
0.11
9.55%
0.14
31.35%
shareholders equity per share
-3.36
-
7.04
309.74%
2.63
62.73%
2.34
10.88%
2.46
5.33%
1.22
50.54%
stock based compensation to revenue
0.02
-
0.00
78.31%
0.10
2,110.78%
0.01
86.77%
0.01
21.87%
0.01
30.31%
0.01
6.08%
0.01
22.16%
tangible asset value
-446.63M
-
-1.18B
165.29%
-1.46B
22.84%
-1.48B
1.86%
-1.39B
6.04%
-1.49B
6.68%
tangible book value per share
-3.89
-
-9.31
139.45%
-11.02
18.33%
-10.05
8.74%
-9.35
6.97%
-9.84
5.25%
working capital
475.05M
-
732.79M
54.26%
659.80M
9.96%
874.64M
32.56%
842.87M
3.63%
659.02M
21.81%

All numbers in (except ratios and percentages)